Additionally, a study has demonstrated that SARS-CoV infection can lead to the downregulation of ACE2 and activate the renin-angiotensin-aldosterone system (RASS), which would further increase the cardiovascular burden and contribute to adverse outcomes (7) (Figure 1). This evidence concerns the gene ACE2 and severe acute respiratory syndrome.